Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...
A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...
Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...
DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across Europe ...
The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.
An Oklahoma lawmaker is hoping to help those who rely on insulin for their diabetes. An Oklahoma lawmaker is hoping to help ...
14d
Inquirer Technology on MSNUS approves 1st fast-acting insulin biosimilar for diabetesThe US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls the new drug “Merilog,” a biosimilar to the widely-used insulin product ...
The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.The report is built to visualize ...
South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
Q: I saw an advertisement in a magazine for a needle-free insulin pen. Can you tell me more about how this works and is it something I can get from the pharmacy?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results